P1272: GP130/STAT3 AXIS IS A POTENTIAL THERAPEUTIC TARGET FOR HISTONE DEACETYLASE INHIBITOR-RESISTANT CUTANEOUS T-CELL LYMPHOMA

• Y. Takahashi,
• A. Kitadate,
• S. Ikeda,
• S. Iwama,
• K. Abe,
• Y. Matsuda,
• H. Tagawa,
• H. Wakui,
• N. Takahashi

Affiliations

Y. Takahashi

1 Department of Life Science, Graduate School of Engineering Science, Akita University

A. Kitadate

2 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

S. Ikeda

2 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

S. Iwama

1 Department of Life Science, Graduate School of Engineering Science, Akita University

K. Abe

2 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

Y. Matsuda

1 Department of Life Science, Graduate School of Engineering Science, Akita University

H. Tagawa

2 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

H. Wakui

1 Department of Life Science, Graduate School of Engineering Science, Akita University

N. Takahashi

2 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan